Bradford Zakes
Amministratore Delegato presso Longevity Biomedical, Inc.
Profilo
Bradford A.
Zakes is currently the Chairman, President & CEO at Cerevast Medical, Inc., CEO at Longevity Biomedical, Inc., President, CEO & Director at Longevity Biomedical, Inc., and Director at Biotechnology Innovation Organization.
Previously, he was the President & CEO at ImaRx Therapeutics, Inc. from 2006 to 2009, Director-Business Management at ICOS Corp.
from 2001 to 2005, and President at Heart Research Centers International LLC from 1999 to 2001.
Zakes holds an MBA from Duke University, a graduate degree from American University, and an undergraduate degree from Oregon State University.
Posizioni attive di Bradford Zakes
| Società | Posizione | Inizio |
|---|---|---|
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Direttore/Membro del Consiglio | - |
Cerevast Medical, Inc.
 Cerevast Medical, Inc. Investment ManagersFinance Cerevast Neurorehab, Inc. operates as neuroscience medical device technology company. It develops a therapy for the treatment of acute ischemic stroke. The firm offers ClotBust-ER, an operator independent device, which helps in administering ultrasound energy for sonothrombolysis therapy. The company was founded in 2009 and is headquartered in Redmond, WA. | Amministratore Delegato | 01/06/2009 |
Longevity Biomedical, Inc.
 Longevity Biomedical, Inc. BiotechnologyHealth Technology Longevity Biomedical, Inc. is a biopharmaceutical company that focuses on advancing new technologies across therapeutics, health monitoring, and digital health solutions to increase human health span. The private company is based in Bothell, WA. The CEO of the company is Bradford A. Zakes. | Amministratore Delegato | - |
Precedenti posizioni note di Bradford Zakes
| Società | Posizione | Fine |
|---|---|---|
ImaRx Therapeutics, Inc.
 ImaRx Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ImaRx Therapeutics, Inc. manufactures biopharmaceutical products. The company develops and manufactures therapies for vascular disorders associated with blood clots based on two programs, thrombolytics and sonoLysis. Its therapeutics products are approved by the US Food, Drug Administration and FDA, for the treatment of acute pulmonary embolism or blood clots in the lungs. The company was founded in 1991 and is headquartered in Los Angeles, CA | Presidente | 18/09/2009 |
ICOS Corp.
 ICOS Corp. Pharmaceuticals: OtherHealth Technology ICOS Corp. manufactures medications to treat inflammation and other serious diseases. It focuses on the development of treatments for unmet medical conditions such as prostatic hyperplasia, hypertension, pulmonary arterial hypertension, cancer, and inflammatory diseases. The company was founded in 1989 by Christopher Henney and George Rathman and is headquartered in Bothell, WA. | Corporate Officer/Principal | 01/08/2005 |
| Heart Research Centers International LLC | Presidente | 01/12/2001 |
Formazione di Bradford Zakes
| Duke University | Masters Business Admin |
| American University | Graduate Degree |
| Oregon State University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 6 |
|---|---|
ICOS Corp.
ICOS Corp. Pharmaceuticals: OtherHealth Technology ICOS Corp. manufactures medications to treat inflammation and other serious diseases. It focuses on the development of treatments for unmet medical conditions such as prostatic hyperplasia, hypertension, pulmonary arterial hypertension, cancer, and inflammatory diseases. The company was founded in 1989 by Christopher Henney and George Rathman and is headquartered in Bothell, WA. | Health Technology |
ImaRx Therapeutics, Inc.
ImaRx Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ImaRx Therapeutics, Inc. manufactures biopharmaceutical products. The company develops and manufactures therapies for vascular disorders associated with blood clots based on two programs, thrombolytics and sonoLysis. Its therapeutics products are approved by the US Food, Drug Administration and FDA, for the treatment of acute pulmonary embolism or blood clots in the lungs. The company was founded in 1991 and is headquartered in Los Angeles, CA | Health Technology |
| Heart Research Centers International LLC | |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Commercial Services |
Cerevast Medical, Inc.
Cerevast Medical, Inc. Investment ManagersFinance Cerevast Neurorehab, Inc. operates as neuroscience medical device technology company. It develops a therapy for the treatment of acute ischemic stroke. The firm offers ClotBust-ER, an operator independent device, which helps in administering ultrasound energy for sonothrombolysis therapy. The company was founded in 2009 and is headquartered in Redmond, WA. | Finance |
Longevity Biomedical, Inc.
Longevity Biomedical, Inc. BiotechnologyHealth Technology Longevity Biomedical, Inc. is a biopharmaceutical company that focuses on advancing new technologies across therapeutics, health monitoring, and digital health solutions to increase human health span. The private company is based in Bothell, WA. The CEO of the company is Bradford A. Zakes. | Health Technology |
- Borsa valori
- Insiders
- Bradford Zakes